Takeda plans 2008 release of Prevacid successor

08/12/2005 | Reuters

Japan's Takeda Pharmaceutical plans to launch a successor to its top-selling anti-ulcer drug Prevacid in 2008, one year before the drug's patent expires. The company is working with Abbott Laboratories to develop the new drug. Prevacid had global sales of $3.4 billion in the last year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD